• Aucun résultat trouvé

Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study

N/A
N/A
Protected

Academic year: 2021

Partager "Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study"

Copied!
10
0
0

Texte intégral

Loading

Figure

FIGURE 1 | Patient enrolement and virological assessment.
TABLE 2 | Factors associated with PI-based second-line regimen success at time of inclusion (N  =  1,281).
FIGURE 2 | HIV Reverse transcriptase (A) and protease (B) drug resistance mutations among patients with confirmed virological second time treatment failure.

Références

Documents relatifs

La surcharge de travail et de pensées provoquée par l’articulation de mon activité, de la formation et de l’écriture de ce travail m’a obligée de me repositionner très souvent :

De plus, le juge examine d’office les conditions de recevabilité de la demande (art 60 CPC), et le code énonce expressément qu’une action en paiement d’une somme d’argent doit

3TC: lamivudine; ABI: applied biosystem; AIDS: acquired immunodeficiency syndrome; ANRS: agence nationale pour la recherche sur le SIDA et les hépati‑ tis virales; ARV:

The measure based on current missed doses had only low sensitivity; cumulative missed doses reported at M12 performed better for detecting virological failure (significant AUC test

(2020) Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d’Ivoire West Africa.. PLoS ONE

(2014) Virological Failure and HIV-1 Drug Resistance Mutations among Naive and Antiretroviral Pre-Treated Patients Entering the ESTHER Program of Calmette Hospital in Cambodia.. This

Figure 2: Trough plasma concentrations of etravirine (ETR), nevirapine (NVP), lopinavir (LPV), darunavir once daily and twice daily (DRV QD and DRV BID), atazanavir (ATV)

“Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania,” Clinical